Skip to main content

Table 4 Risk factors for malignancy in RS3PE by logistic models

From: bFGF could be a biomarker of malignancy in RS3PE syndrome: an ambispective single-center cohort analysis of 51 patients

Variables

Univariate analysis

Multivariate analysis

B

OR (95%CI)

P

B

OR (95%CI)

P

Male

0.411

1.508 (0.317–7.177)

0.606

   

Bilateral pitting edema of hands

−2.61

0.074 (0.006–0.968)

0.047

−1.255

0.285 (0.035–2.320)

0.068

Good response to prednisolone

−3.232

0.039 (0.005–0.311)

0.002

−1.967

0.140 (0.017–1.182)

0.071

bFGF>10ng/ml

2.651

14.084 (2.421–83.332)

0.003

2.686

14.667 (2.029–106.038)

0.008

  1. RS3PE remitting seronegative symmetrical synovitis with pitting edema, bFGF basic fibroblast growth factor